In a groundbreaking development, Strand Therapeutics has revealed the initial Phase 1 data for STX-001 in patients with advanced solid tumors. This mRNA therapeutic aims to address the urgent need for new treatment options in patients who are resistant to immune checkpoint inhibitors. By delivering localized IL-12 expression to activate the tumor microenvironment and stimulate […]
Category: therapeutics
Maryland Dispensaries to Offer Adult-Use Marijuana Sales
Get ready, Maryland! Nearly 100 cannabis dispensaries across the state are gearing up to make history by offering marijuana to all adults over the age of 21. Starting this Saturday, residents can legally purchase cannabis products for recreational use. Ember Therapeutics is at the forefront of this exciting development, providing high-quality products to meet the […]
Advancements in Epigenome Editing
In a significant development, Modalis Therapeutics has received a coveted paediatric disease designation from the US Food and Drug Administration for their innovative work in epigenome editing. This breakthrough technology holds the promise of revolutionizing the treatment of various genetic disorders by modifying gene expression at the epigenetic level. Epigenome editing involves precise modifications to […]
